RECRO PHARMA INC

CUSIP: 75629F109 Class: COMMON

Caligan Partners LP's Holding History (CIK: 0001727492)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 1,689,768 Value ($000) $592 Avg Close — Range —
Q3 2023
Shares 1,689,768 Value ($000) $794 Avg Close — Range —
Q2 2023
Shares 1,077,268 Value ($000) $1,185 Avg Close — Range —
Q1 2023
Shares 1,077,268 Value ($000) $1,282 Avg Close — Range —
Q4 2022
Shares 1,603,214 Value ($000) $2,389 Avg Close — Range —